ES2716674T3 - Célula congelada lista para ensayo y método para minimizar variabilidad en el rendimiento de la misma - Google Patents
Célula congelada lista para ensayo y método para minimizar variabilidad en el rendimiento de la misma Download PDFInfo
- Publication number
- ES2716674T3 ES2716674T3 ES14821336T ES14821336T ES2716674T3 ES 2716674 T3 ES2716674 T3 ES 2716674T3 ES 14821336 T ES14821336 T ES 14821336T ES 14821336 T ES14821336 T ES 14821336T ES 2716674 T3 ES2716674 T3 ES 2716674T3
- Authority
- ES
- Spain
- Prior art keywords
- frozen
- eukaryotic cell
- ready
- cells
- assay
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000012360 testing method Methods 0.000 title claims description 38
- 238000000034 method Methods 0.000 title claims description 14
- 210000004027 cell Anatomy 0.000 claims description 127
- 238000003556 assay Methods 0.000 claims description 61
- 210000003527 eukaryotic cell Anatomy 0.000 claims description 47
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 44
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 39
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethyl sulfoxide Natural products CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 39
- 239000000203 mixture Substances 0.000 claims description 39
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 claims description 30
- 229960003048 vinblastine Drugs 0.000 claims description 30
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 claims description 28
- 229960003459 allopurinol Drugs 0.000 claims description 28
- 230000002927 anti-mitotic effect Effects 0.000 claims description 26
- 239000003795 chemical substances by application Substances 0.000 claims description 26
- 230000000861 pro-apoptotic effect Effects 0.000 claims description 26
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 25
- 239000012091 fetal bovine serum Substances 0.000 claims description 25
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 claims description 23
- 229960004308 acetylcysteine Drugs 0.000 claims description 23
- 230000000694 effects Effects 0.000 claims description 19
- 230000002338 cryopreservative effect Effects 0.000 claims description 16
- 229960003180 glutathione Drugs 0.000 claims description 15
- 239000003642 reactive oxygen metabolite Substances 0.000 claims description 14
- 238000010257 thawing Methods 0.000 claims description 14
- 238000003860 storage Methods 0.000 claims description 13
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims description 8
- 230000019491 signal transduction Effects 0.000 claims description 7
- 239000003153 chemical reaction reagent Substances 0.000 claims description 6
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 claims description 5
- 229960004316 cisplatin Drugs 0.000 claims description 5
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims description 4
- 108700008625 Reporter Genes Proteins 0.000 claims description 4
- 229960004679 doxorubicin Drugs 0.000 claims description 4
- 229960002949 fluorouracil Drugs 0.000 claims description 4
- 102000018697 Membrane Proteins Human genes 0.000 claims description 3
- 108010052285 Membrane Proteins Proteins 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 230000004044 response Effects 0.000 claims description 3
- 241000251468 Actinopterygii Species 0.000 claims description 2
- 241000271566 Aves Species 0.000 claims description 2
- 241000252212 Danio rerio Species 0.000 claims description 2
- 241000287828 Gallus gallus Species 0.000 claims description 2
- 241000238631 Hexapoda Species 0.000 claims description 2
- 210000004962 mammalian cell Anatomy 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 claims description 2
- 125000003729 nucleotide group Chemical group 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 claims 4
- 238000013518 transcription Methods 0.000 claims 1
- 230000035897 transcription Effects 0.000 claims 1
- JXLYSJRDGCGARV-CFWMRBGOSA-N vinblastine Chemical compound C([C@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-CFWMRBGOSA-N 0.000 description 28
- 108090000331 Firefly luciferases Proteins 0.000 description 23
- 238000007710 freezing Methods 0.000 description 15
- 230000008014 freezing Effects 0.000 description 15
- 108010052090 Renilla Luciferases Proteins 0.000 description 12
- 239000003064 xanthine oxidase inhibitor Substances 0.000 description 8
- 101100243961 Arabidopsis thaliana PIF1 gene Proteins 0.000 description 7
- 229940123769 Xanthine oxidase inhibitor Drugs 0.000 description 7
- 230000006907 apoptotic process Effects 0.000 description 7
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- 238000005138 cryopreservation Methods 0.000 description 6
- 230000006698 induction Effects 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 239000002609 medium Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 4
- 102100033220 Xanthine oxidase Human genes 0.000 description 4
- 108010093894 Xanthine oxidase Proteins 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 239000003446 ligand Substances 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 108700012920 TNF Proteins 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000006037 cell lysis Effects 0.000 description 3
- 239000013043 chemical agent Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 2
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000001640 apoptogenic effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229960004857 mitomycin Drugs 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 230000006950 reactive oxygen species formation Effects 0.000 description 2
- 238000003571 reporter gene assay Methods 0.000 description 2
- RZJQGNCSTQAWON-UHFFFAOYSA-N rofecoxib Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=C(C=2C=CC=CC=2)C(=O)OC1 RZJQGNCSTQAWON-UHFFFAOYSA-N 0.000 description 2
- 238000003567 signal transduction assay Methods 0.000 description 2
- 229940087652 vioxx Drugs 0.000 description 2
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 101150071146 COX2 gene Proteins 0.000 description 1
- 101100114534 Caenorhabditis elegans ctc-2 gene Proteins 0.000 description 1
- 102000011727 Caspases Human genes 0.000 description 1
- 108010076667 Caspases Proteins 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229940122204 Cyclooxygenase inhibitor Drugs 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 208000031637 Erythroblastic Acute Leukemia Diseases 0.000 description 1
- 208000036566 Erythroleukaemia Diseases 0.000 description 1
- 238000012424 Freeze-thaw process Methods 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- DAQAKHDKYAWHCG-UHFFFAOYSA-N Lactacystin Natural products CC(=O)NC(C(O)=O)CSC(=O)C1(C(O)C(C)C)NC(=O)C(C)C1O DAQAKHDKYAWHCG-UHFFFAOYSA-N 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 108010047357 Luminescent Proteins Proteins 0.000 description 1
- 102000006830 Luminescent Proteins Human genes 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- UBQYURCVBFRUQT-UHFFFAOYSA-N N-benzoyl-Ferrioxamine B Chemical compound CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN UBQYURCVBFRUQT-UHFFFAOYSA-N 0.000 description 1
- 101150000187 PTGS2 gene Proteins 0.000 description 1
- 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 1
- 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 1
- 229940079156 Proteasome inhibitor Drugs 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 206010042971 T-cell lymphoma Diseases 0.000 description 1
- 208000027585 T-cell non-Hodgkin lymphoma Diseases 0.000 description 1
- ISWQCIVKKSOKNN-UHFFFAOYSA-L Tiron Chemical compound [Na+].[Na+].OC1=CC(S([O-])(=O)=O)=CC(S([O-])(=O)=O)=C1O ISWQCIVKKSOKNN-UHFFFAOYSA-L 0.000 description 1
- 101000942305 Zea mays Cytokinin dehydrogenase 1 Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 208000021841 acute erythroid leukemia Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000003080 antimitotic agent Substances 0.000 description 1
- 201000008274 breast adenocarcinoma Diseases 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000000423 cell based assay Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- OEUUFNIKLCFNLN-LLVKDONJSA-N chembl432481 Chemical compound OC(=O)[C@@]1(C)CSC(C=2C(=CC(O)=CC=2)O)=N1 OEUUFNIKLCFNLN-LLVKDONJSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229940111134 coxibs Drugs 0.000 description 1
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 229960000958 deferoxamine Drugs 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- HKSZLNNOFSGOKW-UHFFFAOYSA-N ent-staurosporine Natural products C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1C1CC(NC)C(OC)C4(C)O1 HKSZLNNOFSGOKW-UHFFFAOYSA-N 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000000925 erythroid effect Effects 0.000 description 1
- 239000012595 freezing medium Substances 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- DAQAKHDKYAWHCG-RWTHQLGUSA-N lactacystin Chemical compound CC(=O)N[C@H](C(O)=O)CSC(=O)[C@]1([C@@H](O)C(C)C)NC(=O)[C@H](C)[C@@H]1O DAQAKHDKYAWHCG-RWTHQLGUSA-N 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 102000007863 pattern recognition receptors Human genes 0.000 description 1
- 108010089193 pattern recognition receptors Proteins 0.000 description 1
- 108010091212 pepstatin Proteins 0.000 description 1
- FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000002599 prostaglandin synthase inhibitor Substances 0.000 description 1
- 239000003207 proteasome inhibitor Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- HKSZLNNOFSGOKW-FYTWVXJKSA-N staurosporine Chemical compound C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1[C@H]1C[C@@H](NC)[C@@H](OC)[C@]4(C)O1 HKSZLNNOFSGOKW-FYTWVXJKSA-N 0.000 description 1
- CGPUWJWCVCFERF-UHFFFAOYSA-N staurosporine Natural products C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1C1CC(NC)C(OC)C4(OC)O1 CGPUWJWCVCFERF-UHFFFAOYSA-N 0.000 description 1
- FAGUFWYHJQFNRV-UHFFFAOYSA-N tetraethylenepentamine Chemical compound NCCNCCNCCNCCN FAGUFWYHJQFNRV-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000034512 ubiquitination Effects 0.000 description 1
- 238000010798 ubiquitination Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Biophysics (AREA)
- Physiology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361907631P | 2013-11-22 | 2013-11-22 | |
| US201361920061P | 2013-12-23 | 2013-12-23 | |
| PCT/US2014/066746 WO2015077523A1 (en) | 2013-11-22 | 2014-11-21 | Assay-ready frozen cell and method for minimizing variability in the performance thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2716674T3 true ES2716674T3 (es) | 2019-06-14 |
Family
ID=52273485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES14821336T Active ES2716674T3 (es) | 2013-11-22 | 2014-11-21 | Célula congelada lista para ensayo y método para minimizar variabilidad en el rendimiento de la misma |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10271539B2 (enExample) |
| EP (1) | EP3071027B1 (enExample) |
| JP (1) | JP6654572B2 (enExample) |
| ES (1) | ES2716674T3 (enExample) |
| WO (1) | WO2015077523A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020516246A (ja) * | 2017-04-07 | 2020-06-11 | スワール ライフ サイエンス エービー | 自動化イムノアッセイプラットフォームでの分析のための細胞ベースアッセイの適応のためのシステム |
| CN109122666B (zh) * | 2018-09-20 | 2021-02-02 | 山东省齐鲁干细胞工程有限公司 | 一种复苏即用型红细胞冷冻保护剂及使用方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4052817A (en) * | 1976-02-23 | 1977-10-11 | Gte Laboratories Incorporated | Process for storing and recovering plant tissue |
| WO1992003046A1 (en) * | 1990-08-28 | 1992-03-05 | Somatix Therapy Corporation | Improved cell cryopreservation method |
| CA2318376A1 (en) | 1998-01-12 | 1999-07-15 | Betagene, Inc. | Compositions and methods for regulated secretion from neuroendocrine cell lines |
| US20030049840A1 (en) * | 1998-10-07 | 2003-03-13 | Demetriou Achilles A. | Cell preconditioning and cryopreservation medium |
| US7470536B2 (en) * | 2002-10-04 | 2008-12-30 | Neutekbio Limited | Gene reporter assay, kit, and cells for determining the presence and/or the level of a molecule that activates signal transduction activity of a cell surface protein |
| NZ573760A (en) * | 2006-06-12 | 2012-01-12 | Jackson Lab | Sperm cryoprotective media comprising monothioglycerol |
| ATE525446T1 (de) * | 2006-07-14 | 2011-10-15 | Univ Hokkaido Nat Univ Corp | Die unterkühlung förderndes mittel |
| JP5590821B2 (ja) * | 2009-05-26 | 2014-09-17 | 国立大学法人京都大学 | 多能性幹細胞用の凍結保存液と多能性幹細胞の凍結保存方法 |
| WO2012164321A1 (en) * | 2011-05-30 | 2012-12-06 | Medicinski Fakultet U Rijeci | Organ and tissue transplantation solution containing bmp-7 |
| KR102023339B1 (ko) * | 2012-07-25 | 2019-09-20 | 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 | 조직 보존액 및 조직 보존 방법 |
-
2014
- 2014-11-21 JP JP2016554813A patent/JP6654572B2/ja active Active
- 2014-11-21 EP EP14821336.6A patent/EP3071027B1/en active Active
- 2014-11-21 WO PCT/US2014/066746 patent/WO2015077523A1/en not_active Ceased
- 2014-11-21 US US15/038,680 patent/US10271539B2/en active Active
- 2014-11-21 ES ES14821336T patent/ES2716674T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20160302405A1 (en) | 2016-10-20 |
| WO2015077523A1 (en) | 2015-05-28 |
| US10271539B2 (en) | 2019-04-30 |
| JP2016537032A (ja) | 2016-12-01 |
| EP3071027A1 (en) | 2016-09-28 |
| JP6654572B2 (ja) | 2020-02-26 |
| EP3071027B1 (en) | 2018-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gualtieri et al. | Mitochondrial dysfunction and oxidative stress caused by cryopreservation in reproductive cells | |
| Will et al. | Biological pH buffers in IVF: help or hindrance to success | |
| Heidari et al. | The role and study of mitochondrial impairment and oxidative stress in cholestasis | |
| ES2232624T3 (es) | Microinyeccion de crioprotectores para la conservacion de celulas. | |
| Foote et al. | Motility and fertility of bull sperm in whole milk extender containing antioxidants | |
| Glenn et al. | Sildenafil citrate improves sperm motility but causes a premature acrosome reaction in vitro | |
| ES2762966T3 (es) | Procedimiento de crioconservación de células con objetivo terapéutico | |
| US11985969B2 (en) | Cryopreservative compositions and methods | |
| US20050277107A1 (en) | Systems and methods for cell preservation | |
| Si et al. | The successful double cryopreservation of rabbit (Oryctolagus cuniculus) semen in large volume using the directional freezing technique with reduced concentration of cryoprotectant | |
| BRPI0712825A2 (pt) | membrana crioprotetora de esperma | |
| Kuznetsov et al. | Cryopreservation of mitochondria and mitochondrial function in cardiac and skeletal muscle fibers | |
| CN105158455A (zh) | 一种提高样品检测精度和准确性的生物样品采集方法、装置、系统、生物样品稳定试剂及应用 | |
| KR20080087148A (ko) | 저온보호 조성물 및 그 이용방법 | |
| ES2716674T3 (es) | Célula congelada lista para ensayo y método para minimizar variabilidad en el rendimiento de la misma | |
| Ili et al. | DNA damaging effect of paclitaxel in the epididymal sperms as a chemotherapeutic agent and possible remedies to prevent this effect: A study on reproductive potential of male cancer patients of reproductive age | |
| ES2684582T3 (es) | Métodos y reactivos para mantener la viabilidad de células cancerosas en tejido eliminado quirúrgicamente | |
| Tiwari et al. | FluorescencePolarization (FP) Assay for Measuring Staphylococcus aureus Membrane Fluidity | |
| Ekici et al. | Cryopreservation studies in aquaculture from past to present: Scientific techniques and quality controls for commercial applications | |
| Kazama et al. | Spontaneous generation of reactive oxygen species and effect on motility and fertilizability of sea urchin spermatozoa | |
| Szeptycki et al. | Cryopreservation of embryos and gametes: past, present, and future | |
| Zhao et al. | Exploring the Cryopreservation Mechanism and Direct Removal Strategy of TAPS in Red Blood Cell Cryopreservation | |
| Zhang et al. | Cis-membrane association of human ATG8 proteins N-terminus mediates autophagy | |
| ARUN | NITROSATIVE STRESS MEDIATED STRUCTURAL AND FUNCTIONAL CHANGES IN CROSSBRED BULLS CRYOPRESERVED SPERMS | |
| Al-Otaibi | Novel cryo-protective agents to improve the quality of cryopreserved mammalian cells |